bf/NASDAQ:IRMD_icon.jpeg

NASDAQ:IRMD

IRadimed Corporation

  • Stock

USD

Last Close

42.45

14/05 20:00

Market Cap

543.55M

Beta: 1.08

Volume Today

26.29K

Avg: 38.96K

PE Ratio

33.83

PFCF: 145.68

Dividend Yield

3.83%

Payout:157.92%

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.36M
-
1.73M
27.14%
2.25M
30.09%
3.13M
39.05%
4.05M
29.15%
4.14M
2.13%
3.85M
6.88%
3.79M
1.63%
4.12M
8.69%
4.83M
17.43%
average payables
417.95K
-
528.32K
26.41%
817.31K
54.70%
1.06M
30.08%
888.78K
16.40%
714.60K
19.60%
883.11K
23.58%
825.40K
6.53%
719.98K
12.77%
1.29M
79.33%
average receivables
1.78M
-
1.97M
10.50%
2.91M
47.73%
3.82M
31.17%
3.78M
1.11%
3.99M
5.75%
5.75M
43.99%
5.93M
3.17%
4.86M
18.17%
9.21M
89.58%
book value per share
0.52
-
2.39
358.93%
2.90
21.46%
2.95
1.57%
3.10
5.01%
3.90
25.96%
4.92
26.23%
5.06
2.88%
5.85
15.46%
5.86
0.32%
capex per share
-0.02
-
-0.07
276.65%
-0.03
58.74%
-0.14
392.42%
-0.08
44.98%
-0.02
68.27%
-0.04
75.04%
-0.05
21.97%
-0.06
14.39%
-0.15
148.42%
0.64
525.69%
capex to depreciation
-1.38
-
-4.07
194.92%
-1.41
65.44%
-6.14
336.66%
-0.63
89.73%
-0.24
61.99%
-0.39
63.27%
-0.48
21.62%
-0.53
10.86%
-2.80
430.23%
capex to operating cash flow
-0.13
-
-0.23
80.28%
-0.04
82.45%
-0.16
293.72%
-0.24
49.00%
-0.04
85.14%
-0.05
32.31%
-0.11
130.54%
-0.07
39.80%
-0.19
183.37%
0.59
418.51%
capex to revenue
-0.02
-
-0.04
129.05%
-0.01
74.27%
-0.05
370.70%
-0.04
23.82%
-0.01
75.67%
-0.01
45.06%
-0.02
59.17%
-0.02
11.64%
-0.04
98.30%
0.12
447.20%
cash per share
0.26
-
1.99
664.11%
2.45
23.40%
2.37
3.16%
2.48
4.31%
3.20
29.05%
4.10
28.29%
4.29
4.59%
5.06
18.08%
4.61
8.86%
days of inventory on hand
171.45
-
227.92
32.93%
148.94
34.65%
230.49
54.75%
275.94
19.72%
205.46
25.54%
150.77
26.62%
176.34
16.96%
160.73
8.85%
163.03
1.44%
days payables outstanding
54.68
-
67.46
23.36%
62.84
6.85%
66.47
5.78%
43.04
35.25%
39.10
9.15%
41.14
5.23%
29.45
28.41%
29.26
0.64%
54.63
86.69%
days sales outstanding
63.80
-
45.71
28.35%
44.64
2.35%
42.41
4.99%
59.76
40.91%
50.48
15.52%
69.11
36.90%
52.65
23.82%
44.84
14.84%
90.90
102.73%
debt to assets
0.00
-
0.00
211.38%
0.00
69.15%
0.04
4,183.67%
0.04
16.50%
0.00
93.68%
0.04
1,513.41%
0.04
13.75%
0.03
21.61%
0.03
13.89%
debt to equity
0.00
-
0.00
169.66%
0.00
69.49%
0.04
4,426.94%
0.05
18.32%
0.00
93.84%
0.05
1,578.95%
0.04
16.92%
0.03
22.25%
0.03
12.96%
dividend yield
0.04
-
earnings yield
0.02
-
0.02
3.22%
0.02
34.30%
0.06
146.08%
0.00
94.84%
0.02
672.51%
0.04
52.43%
0.00
86.44%
0.02
230.04%
0.04
120.81%
0.03
20.38%
enterprise value
100.66M
-
103.34M
2.66%
289.05M
179.72%
102.37M
64.58%
142.97M
39.66%
235.13M
64.46%
223.25M
5.05%
229.06M
2.60%
511.00M
123.08%
299.65M
41.36%
enterprise value over ebitda
34.40
-
32.14
6.56%
24.63
23.38%
9.17
62.78%
55.12
501.37%
33.08
39.99%
22.57
31.75%
393.08
1,641.30%
45.53
88.42%
19.17
57.88%
ev to operating cash flow
68.27
-
39.96
41.46%
37.79
5.45%
10.88
71.20%
41.85
284.58%
31.88
23.84%
21.82
31.56%
39.37
80.47%
45.39
15.27%
29.84
34.26%
ev to sales
8.88
-
6.60
25.63%
9.15
38.59%
3.15
65.57%
6.19
96.63%
7.72
24.71%
5.80
24.97%
7.22
24.60%
12.22
69.21%
5.62
54.00%
free cash flow per share
0.12
-
0.23
83.85%
0.67
194.44%
0.73
9.30%
0.24
66.57%
0.66
171.39%
0.86
30.70%
0.43
50.54%
0.85
99.33%
0.65
23.67%
1.70
162.05%
free cash flow yield
0.01
-
0.02
41.09%
0.02
35.51%
0.07
176.01%
0.02
75.51%
0.03
68.09%
0.04
36.74%
0.02
49.28%
0.02
1.65%
0.02
24.68%
0.04
56.17%
graham net net
0.32
-
2.00
531.02%
2.52
26.13%
2.32
7.82%
2.37
1.89%
3.07
29.77%
3.75
22.09%
3.93
4.84%
4.68
19.00%
4.68
0.08%
graham number
1.48
-
3.55
140.57%
6.68
88.27%
6.65
0.51%
1.81
72.80%
7.17
296.35%
9.72
35.62%
3.59
63.11%
9.97
177.90%
11.61
16.45%
income quality
0.76
-
1.26
65.67%
1.02
19.45%
1.30
28.34%
6.84
424.24%
1.17
82.88%
1.06
9.20%
4.25
299.95%
1.21
71.59%
0.78
35.15%
intangibles to total assets
0.04
-
0.01
71.84%
0.00
53.72%
0.02
396.00%
0.02
8.11%
0.02
24.28%
0.01
25.00%
0.01
4.90%
0.01
0.18%
0.02
79.31%
0
100%
interest coverage
26.86
-
interest debt per share
0.00
-
0.01
1,137.56%
0.00
62.94%
0.13
4,497.95%
0.16
24.25%
0.01
92.24%
0.26
2,019.35%
0.22
14.52%
0.20
10.23%
0.22
10.35%
inventory turnover
2.13
-
1.60
24.78%
2.45
53.03%
1.58
35.38%
1.32
16.47%
1.78
34.30%
2.42
36.28%
2.07
14.50%
2.27
9.71%
2.24
1.42%
invested capital
0.00
-
0.00
169.66%
0.00
69.49%
0.04
4,426.94%
0.05
18.32%
0.00
93.84%
0.05
1,578.95%
0.04
16.92%
0.03
22.25%
0.03
12.96%
market cap
103.12M
-
112.79M
9.38%
308.42M
173.45%
120.08M
61.06%
161.18M
34.22%
263.16M
63.27%
263.78M
0.24%
276.42M
4.79%
570.52M
106.40%
355.40M
37.71%
598.26M
68.33%
net current asset value
4.82M
-
19.75M
309.71%
30.64M
55.15%
28.86M
5.80%
29.03M
0.56%
38.05M
31.07%
47.76M
25.53%
54.05M
13.18%
65.54M
21.24%
66.35M
1.24%
net debt to ebitda
-0.84
-
-2.94
250.49%
-1.65
43.89%
-1.59
3.88%
-7.02
342.55%
-3.94
43.83%
-4.10
3.93%
-81.26
1,883.06%
-5.30
93.47%
-3.57
32.72%
net income per share
0.19
-
0.23
26.11%
0.68
191.82%
0.67
2.55%
0.05
92.96%
0.59
1,147.23%
0.85
45.70%
0.11
86.77%
0.76
568.91%
1.02
35.18%
1.36
33.61%
operating cash flow per share
0.14
-
0.30
108.92%
0.70
135.07%
0.87
25.07%
0.32
63.07%
0.69
113.52%
0.91
32.29%
0.48
47.09%
0.91
90.03%
0.80
12.33%
1.07
33.65%
payables turnover
6.67
-
5.41
18.94%
5.81
7.35%
5.49
5.46%
8.48
54.45%
9.34
10.07%
8.87
4.97%
12.39
39.69%
12.47
0.64%
6.68
46.44%
receivables turnover
5.72
-
7.99
39.57%
8.18
2.40%
8.61
5.25%
6.11
29.03%
7.23
18.37%
5.28
26.96%
6.93
31.28%
8.14
17.42%
4.02
50.67%
research and ddevelopement to revenue
0.09
-
0.07
23.34%
0.06
18.20%
0.04
25.75%
0.07
79.98%
0.05
33.22%
0.04
25.37%
0.06
61.26%
0.05
24.05%
0.04
6.19%
0.04
2.02%
return on tangible assets
0.29
-
0.09
69.15%
0.21
141.48%
0.20
7.38%
0.01
93.41%
0.13
910.07%
0.15
10.44%
0.02
86.64%
0.11
484.07%
0.15
34.78%
revenue per share
1.09
-
1.79
64.44%
2.87
60.38%
3.00
4.62%
2.17
27.77%
2.83
30.41%
3.41
20.67%
2.62
23.37%
3.39
29.46%
4.24
25.28%
5.20
22.61%
roe
0.36
-
0.10
72.52%
0.24
140.25%
0.23
4.06%
0.02
93.29%
0.15
890.21%
0.17
15.42%
0.02
87.14%
0.13
479.36%
0.17
34.76%
roic
0.36
-
0.10
72.17%
0.23
134.49%
0.22
7.28%
0.01
93.86%
0.15
992.63%
0.15
3.29%
0.03
83.25%
0.12
380.48%
0.16
31.49%
sales general and administrative to revenue
0.21
-
0.31
45.87%
0.25
20.08%
0.27
10.06%
0.39
44.08%
0.29
26.62%
0.27
5.18%
0.39
42.56%
0.23
39.59%
0.20
14.12%
0.23
14.93%
shareholders equity per share
0.52
-
2.39
358.93%
2.90
21.46%
2.95
1.57%
3.10
5.01%
3.90
25.96%
4.92
26.23%
5.06
2.88%
5.85
15.46%
5.86
0.32%
stock based compensation to revenue
0.02
-
0.05
92.91%
0.04
16.51%
0.06
46.77%
0.11
87.60%
0.06
45.49%
0.05
16.91%
0.12
159.38%
0.03
72.06%
0.03
25.06%
tangible asset value
5.16M
-
20.64M
300.33%
31.76M
53.86%
30.97M
2.48%
32.05M
3.47%
41.11M
28.30%
54.66M
32.96%
60.42M
10.54%
71.06M
17.59%
71.60M
0.77%
tangible book value per share
0.49
-
2.36
376.90%
2.89
22.26%
2.86
0.81%
3.01
5.22%
3.82
26.87%
4.85
26.79%
4.98
2.87%
5.76
15.47%
5.70
0.97%
working capital
4.93M
-
19.89M
303.32%
31.06M
56.12%
30.51M
1.77%
31.03M
1.72%
39.85M
28.43%
53.10M
33.25%
58.82M
10.76%
69.42M
18.03%
69.64M
0.31%

All numbers in USD (except ratios and percentages)